InvestorsHub Logo
Followers 439
Posts 18663
Boards Moderated 0
Alias Born 09/10/2000

Re: None

Sunday, 03/05/2023 9:22:27 PM

Sunday, March 05, 2023 9:22:27 PM

Post# of 629
FDA Accepts Eisai's Filing of a Supplemental Biologics License Application and Grants Priority Review for Traditional Approval of LEQEMBI™ (lecanemab-irmb) for the Treatment of Alzheimer's Disease

The Dog that doesn't bark is the one to pay attention to

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BIIB News